Lite Strategy LITS
NASDAQ LITS
$1.16 -0.03 (-2.52%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Lite Strategy (LITS) recorded Return on Capital Employed [ROCE] of -135.40% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 39.37 percentage points from -96.02% a year earlier and down 51.70 percentage points from the prior quarter.

Analysis

Lite Strategy (LITS) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Lite Strategy reported Return on Capital Employed [ROCE] of -226.30%, down 165.01 percentage points from FY2025.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -191.11 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, Return on Capital Employed [ROCE] came in at -61.30% in FY2025 (-81.29 pp), 19.99% in FY2024 (+48.50 pp), -28.50% in FY2023 (+21.31 pp) and -49.82% in FY2022 (-14.62 pp).
  • The fiscal Q4 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q3 2025.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in three of the last eight quarters, with an average year-over-year change of -49.92 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 135.07 percentage points in fiscal Q1 2026, against a drop of 191.60 percentage points in fiscal Q3 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -83.70% (Q3 2026), -40.45% (Q2 2026) and -19.84% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.52%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 17.92%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.28%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 16.76%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -5.97%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.86%
10 Lite Strategy 40.43 Mn 8.31 Mn - -135.40%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -135.40%
Mar 31, 2026 -83.70%
Dec 31, 2025 -40.45%
Sep 30, 2025 -19.84%
Jun 30, 2025 -96.02%
Mar 31, 2025 -157.22%
Dec 31, 2024 -170.78%
Sep 30, 2024 -154.91%
Jun 30, 2024 30.32%
Mar 31, 2024 34.38%
Dec 31, 2023 19.40%
Sep 30, 2023 35.85%
Jun 30, 2023 -34.31%
Mar 31, 2023 -35.71%
Dec 31, 2022 -35.39%
Sep 30, 2022 -49.97%
Jun 30, 2022 -46.68%
Mar 31, 2022 -42.00%
Dec 31, 2021 -40.88%
Sep 30, 2021 -43.88%
API Access

Lite Strategy Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LITS&period=max&api_key=YOUR_API_KEY